Ibogaine treatment for Las Vegas residents: the physician-prescribed pathway through Brazil

Ibogaine is a Schedule I controlled substance in the United States. No clinic, hospital, or physician in Nevada can legally prescribe or administer it. That policy gap is not closing soon, even as Carson City has begun engaging the question.

In 2023, Governor Joe Lombardo signed Senate Bill 242, establishing Nevada's Psychedelic Medicines Working Group to study entheogens in therapeutic settings. In 2025, the legislature adopted Senate Joint Resolution 10 with bipartisan support, urging Congress to increase federal research funding, establish Right to Try pathways for investigational psychedelics, and reschedule ibogaine and related compounds. Assembly Bill 378, which would have created a psychedelic therapy pilot for veterans and first responders, did not advance in the 2025 session.

That policy momentum matters — Las Vegas Sun reporting from April 2026 describes Nevada advocates watching federal ibogaine research closely, especially for veterans connected to Nellis Air Force Base and the region's large military community. It does not help someone in active addiction today.

Clark County's overdose trajectory makes the stakes visible. After 692 deaths in 2023, the county recorded 802 confirmed deaths in 2024 — a reversal of hope for families watching the toll climb again. Fentanyl drives the crisis, often alongside methamphetamine in polysubstance combinations. The highest opioid death rate in 2023 clustered in ZIP code 89101. Las Vegas's port-adjacent trafficking corridors and 24-hour economy intersect with substance-use risk factors that conventional treatment alone has not contained.

If your loved one is in active addiction, you have probably heard a lot of clinical language that did not translate into results. Ibogaine is worth understanding differently, because it works differently.

Ibogaine is a naturally occurring compound derived from the root bark of the iboga plant. It acts on multiple receptor systems simultaneously, including opioid receptors, NMDA receptors, and serotonin pathways. The result, for many patients, is a dramatic reduction in acute opioid withdrawal symptoms and a reset of the neurological patterns that drive compulsive use. The full receptor-level mechanism is covered in detail on our ibogaine overview.

What makes ibogaine different from medication-assisted treatment goes beyond pharmacology. It is the window that opens after. In the weeks following a session, the brain enters a period of elevated neuroplasticity, sometimes called the Window of Wonder, that typically lasts 2 to 12 weeks. This is not a passive recovery period. It is the window that Nekawa's 15-day on-site integration and 45-day at-home coursework are specifically built around, because what a student does during that window shapes what the session becomes long-term.

Ibogaine is not appropriate for everyone. The peer-reviewed research is serious and growing, and so is the understanding of who is and is not a candidate. Cardiac history, current medications, and other health factors all matter. That is precisely why the physician-prescribed pathway requires a full medical workup before any session proceeds.

The ibogaine session at the heart of Nekawa's program is prescribed and administered by independent licensed Brazilian physicians, not by Nekawa. Understanding what that means in practice matters, because it is the difference between a supervised medical procedure and an unmonitored retreat experience.

Before the prescribing physicians clear a patient for ibogaine, the workup includes:

• EKG
• QT-interval check
• Comprehensive blood panel
• Liver function test
• Magnesium loading

The QT-interval check is the critical cardiac screen. Ibogaine affects cardiac conduction, and a prolonged QT interval is a contraindication. This is not a formality. It is the reason the medical workup exists.

During the session, an on-site physician is present throughout. The hospital's ICU-trained nursing team monitors continuous cardiac telemetry for a minimum of 24 hours post-dose. The session itself moves through distinct phases: the intense visionary phase lasts 6 to 12 hours, followed by roughly 12 hours of quieter mental processing, then 24 to 48 hours of physical recuperation.

Nekawa's role is not clinical. We build the preparation, the environment, and the integration structure around the medical team's work. The full program structure is:

• 10 days of preparation and on-site medical onboarding before the session
• The ibogaine session, administered by the medical team in a hospital setting with continuous cardiac telemetry
• 15 days of structured integration on the property
• 45 days of at-home integration coursework after returning home

Longer on-site programs of up to 90 days are available for students who want deeper transformation work. The 28-day structure is the foundation; the extended program builds on it.

See our cardiac safety overview for the full QT-interval, EKG, and screening protocol the prescribing physicians follow.

Mexico and Costa Rica have become common destinations for ibogaine, and some of the programs there are run by serious people. But the regulatory framework is not the same, and that difference matters when you are talking about a compound that requires continuous cardiac monitoring.

In Brazil, ibogaine is approved for medical use under ANVISA, Brazil's federal health agency, the equivalent of the FDA. Treatment is prescribed by licensed physicians and delivered within hospital infrastructure that includes emergency response capability. This is not a private villa. It is not a retreat center operating in a gray area. The current US and global legal status of ibogaine makes clear why the structure of the Brazilian system is distinct.

Nekawa is a wellness education academy, structured around the hospital infrastructure that physician-administered ibogaine treatment requires. We do not run the medical protocol. The prescribing physicians do. What we provide is the preparation curriculum, the environment, the integration coursework, and the program structure that gives the medical session its full context.

The distinction matters for Las Vegas students specifically. Nevada adopted SJR 10 urging federal rescheduling precisely because the evidence base is credible — and Clark County's fentanyl-driven toll is part of why that policy conversation exists. The Americans for Ibogaine state legislation tracker places Nevada among the states actively engaging on psychedelic research policy. That credibility is built on the kind of physician-prescribed, hospital-administered framework Brazil has operated under for years.

Harry Reid International (LAS) connects to São Paulo–Guarulhos (GRU) or Rio de Janeiro–Galeão (GIG) via one-stop service through Los Angeles, Houston, or Dallas. Total travel time typically runs 14 to 18 hours door to door, depending on connection length.

From either GRU or GIG, it is a 4-hour drive along the BR-101 coastal highway to Paraty, on Brazil's Costa Verde coast. We arrange private ground transport from the airport, so students arrive directly without navigating Brazilian transit or making connections.

What you arrive to is not a medical facility. Our location sits in the Atlantic rainforest, the Mata Atlântica, at the edge of the sea. Old-growth jungle. Waterfalls. A protected lagoon. A bay scattered with more than 300 forested islands. The colonial port town of Paraty is just outside. The environment is part of the program. The preparation and integration work we walk students through is designed to use the setting intentionally.

As of January 1, 2026, US travelers need an approved Brazilian eVisa to enter Brazil. Apply online at brazil.vfsevisa.com.

• Cost: US$80.90
• Processing time: about 72 hours
• Validity: 10 years, multiple entries of up to 90 days per stay
• Passport: US passport with at least 6 months of remaining validity

Our intake team walks every student through this during onboarding.

Nevada has moved further on psychedelic policy than many states — but resolutions and working groups are not treatment access.

Senate Bill 242 (2023) created the Psychedelic Medicines Working Group under the Department of Health and Human Services. SJR 10, adopted in 2025, urges Congress to fund research, streamline FDA approval pathways, establish Right to Try access for investigational psychedelics, and reschedule ibogaine alongside psilocybin, DMT, mescaline, and MDMA. The resolution cites Stanford research on ibogaine's effects on veterans with traumatic brain injury and PTSD.

Assembly Bill 378 would have gone further — a state Alternative Therapy Pilot Program for veterans and first responders — but it did not advance past committee in 2025. No Nevada bill has funded ibogaine clinical trials comparable to Texas's $50 million SB 2308 program.

For a Las Vegas resident in active addiction in 2026, the practical reality is unchanged: no Nevada provider can prescribe or administer ibogaine, and no domestic pilot program offers enrollment. The April 2026 Executive Order directing federal ibogaine research with a focus on veterans is worth following in a military-heavy region — but it does not create treatment access today.

Clark County's 802 confirmed overdose deaths in 2024 underscore why families reach this page despite policy momentum in Carson City.

The ibogaine session is not the end of the program. It is closer to the beginning of the part that requires the most work.

The 45 days of at-home integration coursework that follow the on-site program are structured around the Window of Wonder, the 2 to 12 weeks of elevated neuroplasticity that follow the session. This is when the brain is most receptive to new patterns, and it is when the coursework is designed to be used. Students returning to Las Vegas — to a condo in Summerlin, an apartment in Paradise, or a quiet street in Spring Valley — return to the same environment where the patterns formed. The at-home coursework is built with that reality in mind, including the 24-hour economy, shift-work schedules, and social triggers that make recovery in this city its own challenge.

The Southern Nevada Health District's naloxone distribution, fentanyl test strip mail-order program, and substance use dashboard reflect serious harm-reduction investment. Integration is the complement on the other side of a medical session: structured reflection, specific practices, and ongoing engagement with the material from the preparation phase. Our team remains in contact with students through this period. The work continues.

For students with opioid dependence specifically, the opioid program page covers how the full curriculum is structured for that context. Students navigating burnout, depression, or anxiety alongside addiction may find the burnout and mental health program relevant as well.

The first step is a discovery call. This is a candidacy and program-fit conversation, not a sales call. We are looking at whether Nekawa's program is genuinely right for you or your loved one, and whether you are ready to do what the program requires.

On the call, we cover the program structure, the preparation curriculum, what the on-site experience involves, and what the at-home integration period looks like. We also talk honestly about who the program is not right for. Clinical screening is conducted separately by the prescribing physicians. What we assess is program fit, commitment, and readiness.

If the program is a fit, we move to intake, onboarding, and scheduling. Our intake team handles visa guidance, ground transport coordination, and preparation coursework. You do not navigate this alone.

To start, visit Book a discovery call. If you are a Las Vegas family member trying to understand whether this is the right path, the discovery call is the right place to begin.